Results 1 to 10 of about 418,602 (269)

Leiomyosarcoma: Lung Metastasis

open access: yesCureus, 2023
Uterine leiomyosarcoma distant metastasis is common, and lung metastasis has been reported. However, unique cases have been identified either with late onset of metastatic disease or with large size of lung metastasis. A typical approach to avoid metastasis would be a hysterectomy. Nonetheless, metastatic recurrence is common.
Makhoul, Karim   +4 more
openaire   +2 more sources

Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer

open access: yesCell Death and Disease, 2023
Metastasis remains major cause of treatment failure in non-small cell lung cancer (NSCLC). A comprehensive characterization of the transcriptomic landscape of NSCLC-cells with organ-specific metastatic potentials would advance our understanding of NSCLC ...
Lingling Zu   +5 more
doaj   +1 more source

Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling

open access: yesCell Death and Disease, 2021
Tumor progression requires the communication between tumor cells and tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) are major components of stromal cells.
Yinghui Ren   +11 more
doaj   +1 more source

MiR‐192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway

open access: yesThoracic Cancer, 2022
Background Chemoresistance influences the therapeutic effect of cisplatin and remains a major obstacle to its clinical use. MicroRNAs are associated with drug resistance of various tumors.
Yang Li   +8 more
doaj   +1 more source

Lung Cancer Stem-like Cells and Drug Resistance

open access: yesChinese Journal of Lung Cancer, 2022
Lung cancer remains the leading cause of cancer-related death world-wide. Therapy resistance and relapse are considered major reasons contributing to the poor survival rates of lung cancer.
Zhenhua PAN, Hongyu LIU, Jun CHEN
doaj   +1 more source

Unusual cystic lung metastasis [PDF]

open access: yesBMJ Case Reports, 2018
A 35-year-old woman was recently diagnosed with cervical cancer, confirmed by histology to be squamous cell cancer. A CT of the chest performed as a part of her initial workup did not show any clear evidence of metastasis (figure 1). She underwent chemoradiotherapy with external beam radiotherapy and cisplatin.
Diaeddin Sagar, Aldrin Adeni
openaire   +2 more sources

Cutaneous Metastasis from Lung Adenocarcinoma

open access: yesClinical, Cosmetic and Investigational Dermatology, 2022
Cutaneous metastases are rare and often portend the aggressive malignancy and poor prognosis. We report a case of a 62-year-old man with a rapidly growing nodule on the left back for 2 months. The patient was diagnosed with lung adenocarcinoma shortly before the skin lesion presented.
Lingzhi Zhong   +5 more
openaire   +4 more sources

Lung Metastasis Mimicking Fingertip Infection [PDF]

open access: yesCase Reports in Oncological Medicine, 2015
Metastasis fingers (acral metastasis) are finding a poor prognosis. Past medical history should be questioned and metastasis from primary tumor should be kept in mind in patients with pain, swelling, and hyperemia in fingers. Successful surgical treatment on acral metastasis does not extend the life expectancy; however, it reduces the patient’s pain ...
Salih Soylemez   +5 more
openaire   +3 more sources

Synovial Metastasis from Lung Cancer [PDF]

open access: yesBaylor University Medical Center Proceedings, 2013
Intraarticular masses are infrequently encountered in clinical practice; however, the differential diagnosis can be broad. Neoplasia, both benign and malignant, and proliferative processes are the most common etiologies. We present a case of metastatic disease in the synovium in a patient with a history of lung cancer. Lung carcinoma is the most common
Harold R, Levine   +3 more
openaire   +2 more sources

Symptom trajectories during chemotherapy in patients with non‐small cell lung cancer (NSCLC) and the function of prolonging low dose dexamethasone in promoting enhanced recovery after chemotherapy

open access: yesThoracic Cancer, 2021
Background Lung cancer, mainly non‐small cell lung cancer (NSCLC), is one of the leading causes of death worldwide. Currently, chemotherapy is still the most significant treatment strategy for NSCLC.
Jinghao Liu   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy